A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine

NCT00373113 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

482

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Breast Neoplasms

Interventions

DRUG: Capecitabine
DRUG: Sunitinib malate

Sponsor

Pfizer